Molnupiravir not to be included in COVID-19 clinical management protocol as of now

The experts of the task force cited safety concerns and argued that Molnupiravir was not of much benefit in Covid treatment to arrive at the decision in a meeting held on Monday.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3GhYfqW
via IFTTT